With the latest appointment news, Orthofix also announced that Max Reinhardt has officially begun his role as president of the company’s global spine business. Both Dewey and Reinhardt will serve on Orthofix’s executive leadership team.
Dewey previously held corporate officer roles at multiple global publicly traded medical device companies. She most recently was chief communications and investor relations officer for Treace Medical Concepts.
“We are excited to welcome Julie to the company,” Orthofix President and CEO Massimo Calafiore said in a news release. “She is deeply respected within the industry and brings with her vast knowledge of our markets, technologies, and growth strategies. Her appointment not only strengthens our executive leadership team, but it also further establishes our focus on expanding our outreach with investors and analysts as we continue to drive profitability and growth for our shareholders.”
Dewey has held numerous roles with varying responsibilities within the medical device industry. Prior to Treace, she was chief corporate communications and IR officer at Nevro and senior vice president and chief communications officer at Wright Medical, which was acquired by Stryker in 2020.
“I am thrilled to join Orthofix in this new leadership role at such a transformational time in its growth trajectory,” said Dewey. “I look forward to working with Massimo and the rest of the Orthofix team to execute on the company’s growth strategy and deliver a best-in-class experience for the investment community and key stakeholders.”
Reinhardt’s appointment was previously announced on May 23. He was most recently the worldwide president of DePuy Synthes Spine. Reinhardt will be responsible for leading SeaSpine, Orthofix’s global spine and biologics business, which was created through a massive merger last year.
Dewey’s appointment marks the latest significant leadership move at the Lewisville, Texas-based company. Last fall, the company terminated a trio of executives with cause. Orthofix cut ties with CEO Keith Valentine, CFO John Bostjancic and chief legal officer Patrick Keran following an investigation.
The company then picked former LimaCorporate CEO Massimo Calafiore as its next CEO in November. In January, Julie Andrews took over as CFO, followed by the appointment of Andres Cedron as chief legal officer in April.
